The European Union is banking on big returns from nanotechnology in the fight against AD.
Series
The Mega-Appeal of Nanomedicine
European Union Throws Megabucks at Nanomedicine
Good things come in small packages; at least that’s what the European Union (EU) is banking on. The EU’s current major funding initiative for research, the Seventh Framework Programme (FP7), is making a push for projects that apply nan...
EU Consortium Applies Nanotechnology to Study AD
Most research into nanomedicine, the application of nanoscale materials and processes to medical problems, has focused on cancer. Now researchers are starting to see opportunities for these approaches in Alzheimer’s disease (AD). With its Se...